From: The use of MRI in quantification of the atrial fibrosis in patients with rheumatic mitral disease
 | Paroxysmal AF (n = 10) | Persistent AF (n = 9) | Long-standing AF (n = 11) | P (ANOVA) |
---|---|---|---|---|
Age, year | 28.82 ± 5.71 | 37.56 ± 7.68 | 39.0 ± 9.19 | 0.012 |
Duration of symptoms, month | 21 ± 9.03 | 33.33 ± 17.0 | 39.82 ± 17.23 | 0.031 |
Duration of AF, month | 13.8 ± 4.94 | 7.89 ± 2.02 | 26.2 ± 12.02 | < 0.001 |
Valve area by echo, cm2 | 1.24 ± 0.052 | 1.17 ± 0.132 | 1.10 ± 0.12 | 0.024 |
LA diameter by echo, cm | 4.74 ± 0.12 | 5.17 ± 0.44 | 5.46 ± 0.43 | < 0.001 |
LA diameter/BSA, cm/m2 | 2.53 ± 0.12 | 2.76 ± 0.19 | 3.03 ± 0.27 | < 0.001 |
LA volume by echo, ml | 72.5 ± 1.26 | 78.89 ± 4.78 | 81.91 ± 3.96 | < 0.001 |
LA volume index, ml/m2 | 39.48 ± 1.82 | 41.21 ± 3.01 | 44.08 ± 3.12 | < 0.001 |